目录
更新日期:2025年9月29日
姓 名 马骊 性 别
民 族 回族 导师层次 博士导师
技术职称 教授 导师类型 学术型
最后学历 博士研究生毕业 最后学位 理学博士学位
行政职务 校长 Email maryhmz@126.com
工作单位 检验与生物技术学院 邮政编码 510515
跨学科招生
跨学科招生专业1 医学技术 招生层次类型1 专业学位硕导
跨学科招生专业2 招生层次类型2
个人简介
马骊,南方医科大学副校长、二级教授、博士生导师,广东省免疫学会秘书长,国务院政府特殊津贴专家、国家百千万人才工程人选、国家有突出贡献中青年专家、教育部新世纪优秀人才、广东省丁颖科技奖获得者、广东省高等学校“珠江学者”特聘教授、广东特支计划“百千万工程领军人才”、广东省高等学校“千百十工程”国家级培养对象、广东省南粤优秀教师,当选广东省第十二次和第十三次党代会代表,获得全国三八红旗手、广东省五一劳动奖章、广东省教育系统创先争优优秀共产党员、广东“最美科技工作者”等荣誉称号。
从事结核感染免疫研究。主持国家科技重大专项、国家重点研发计划、国家863计划、国家自然科学基金等科研课题49项;以第一完成人获广东省科技进步一等奖、广东省教育教学成果一等奖;参编免疫学专著4部;以第一/通讯作者在Cell Mol Immunol、EMBO J、EBioMedicine 、Sci Signal、Cell Rep、PLoS Pathog等期刊上发表学术论文131篇;以第一发明人获发明专利授权14项、转让6项;参加研发的rhG-CSF获国家2类新药证书,以1200万元转让企业,实现产业化,这一新药也是广东省内高校研究、异地转让并成功推动承让企业挂牌上市的第一个生物技术药。
研究领域

结核感染免疫

个人成果

近年15篇代表性论文:

[1] Fu YL#, Yang XD#, Ling Q#, Huang YL, You XL, Nie DN, Sheng JL, Chen YT, Wen Q, Zhou XY, Zhou CY, Hu SF*, Ma L*. USP25 promotes the antimycobacterial response of macrophages through stabilizing B-Raf and C-Raf. J Infect Dis. 2025, 231(2):366-377. (最后通讯)

[2] Huang YQ, Li R, Chen S, Wang Q, Han ZY, Liang Y, Liang Y, Li QN, Lin LM, Wen Q, Zhou CY, Zhou XY*, Ma L*. Monocarboxylate transporter 4 facilitates Mycobacterium tuberculosis survival through NF-κB p65 mediated interleukin-10 production. iScience. 2024, 27(8):110238(最后通讯)

[3] Liu HL#, Han ZY#, Chen LR#, Zhang J, Zhang ZQ, Chen YX, Liu FC, Wang K, Liu JY, Sai N, Zhou XY, Zhou CY, Hu SF, Wen Q*, Ma L*. ZNFX1 promotes AMPK-mediated autophagy against Mycobacterium tuberculosis by stabilizing Prkaa2 mRNA. JCI Insight. 2024, 9(1):e171850(最后通讯)

[4] Chen YX, Han ZY, Zhang SA, Liu HL, Wang K, Liu JY, Liu FC, Yu SY, Sai N, Mai HY, Zhou XY, Zhou CY, Wen Q*, Ma L*. ERK1/2-CEBPB axis-regulated hBD1 enhances anti-tuberculosis capacity in alveolar type II epithelial cells. Int J Mol Sci. 2024, 25(4):2408(最后通讯)

[5] Zhang PF*, Yao S, Tang Y, Wan SH, Chen XY, Ma L*. A side-effect-free interventional therapy for precisely eliminating unresectable cancer pain. ACS Nano. 2023,17(23):23535-44(通讯作者)

[6] Zhou XY#*, Xu H#, Li QN, Wang Q, Liu HL, Huang YQ, Liang Y, Lie LM, Han ZY, Chen YX, Huang YL, Zhou WL, Wen Q, Zhou CY, Hu SF, Ma L*. Viperin deficiency promotes dendritic cell activation and function via NF-kappaB activation during Mycobacterium tuberculosis infection. Inflamm Res. 2023,72(1):27-41(通讯作者)

[7] Du XL#, Sheng JL#, Chen YT, He ST, Yang YL, Huan YL, Fu YL, Lie LM, Han ZY, Zhu B, Liu HL, Wen Q, Zhou XY, Zhou CY, Hu SF, Ma L*. The E3 ligase HERC5 promotes antimycobacterial responses in macrophages by ISGylating the phosphatase PTEN. Sci Signal. 2023,16(788):eabm1756(通讯作者)

[8] Zhou XY#, Zhang ZL#, Xu H, Zhu B, Zhang LJ, Lie LM, Huang YQ, Du XL, Liu HL, Li YF, Huang YL, Hu SF, Zhou CY, Wen Q, Pepplenbosch MP, Ma L*. Viperin impairs the innate immune response through the IRAK1-TRAF6-TAK1 axis to promote Mtb infection. Sci Signal. 2022,15(754):eabe1621(通讯作者)

[9] Wen Q#, Li YF#, Han ZY, Liu HL, Zhang SM, Chen YX, He JC, Du XL, Fu YL, Zhang LJ, Zhang ZL, Huang YL, Zhou XY, Zhou CY, Hu SF, Ma L*. β-arrestin 2 regulates inflammatory responses against Mycobacterium tuberculosis infection through modulating ERK1/2 pathway. J Immunol. 2021,206(11): 2623-37(通讯作者)

[10] Zhou XY, Zhang LJ, Lie LM, Zhang ZL, Zhu B, Yang JH, Gao YC, Li PF, Huang YQ, Xu H, Li YF, Du XL, Zhou CY, Hu SF, Wen Q, Zhong XP,Ma L*. MxA suppresses TAK1-IKKα/β-NF-κB mediated inflammatory cytokine production to facilitate Mycobacterium tuberculosis infection. J Infect. 2020,81(2):231-41(通讯作者)

[11] Yang QT, Zhang MX, Chen Q, Chen WX, Wei CL, Qiao K, Ye TS, Deng GF, Li J, Zhu JL, Cai Y, Chen XC, Ma L*. Characterization of human tissue-resident memory T cells at different infection sites in patients with tuberculosis. J Immunol. 2020,204(9):2331-6(通讯作者)

[12] Gao YC, Wen Q, Hu SF, Zhou XY, Xiong WJ, Du XL, Zhang LJ, Fu YL, Yang JH, Zhou CY, Zhang ZL, Li YF, Liu HL, Huang YL, Ma L*. IL-36γ promotes killing of Mycobacterium tuberculosis by macrophages via WNT5A-induced noncanonical WNT signaling. J Immunol. 2019,203(4):922-35(通讯作者)

[13] Zhou XY#, Yang JH#, Zhang ZL, Zhang LJ, Lie LM, Zhu B, Xu L, Gao YC, Du XL, Huang YQ, Wang RN, Liu HL, Li YF, Hu SF, Zhou CY, Wen Q, Pan QW, Ma L*. Interferon regulatory factor 1 eliminates mycobacteria by suppressing p70 S6 kinase via mechanistic target of rapamycin signaling. J Infect. 2019,79(3):262-76(通讯作者)

[14] Hu SF, Du XL, Huang YL, Fu YL, Yang YL, Zhan XX, He WT, Wen Q, Zhou XY, Zhou CY, Zhong XP, Yang JH, Xiong WJ, Wang RN, Gao YC, Ma L*. NLRC3 negatively regulates CD4+ T cells and impacts protective immunity during Mycobacterium tuberculosis infection. PLoS Pathog. 2018,14(8):e1007266(通讯作者)

[15] Xiong WJ, Wen Q, Du XL, Wang JL, He WT, Wang RN, Hu SF, Zhou XY, Yang JH, Gao YC, Ma L*. Novel function of cyclooxygenase-2: suppressing mycobacteria by promoting autophagy via protein kinase B/mammalian target of rapamycin pathway. J Infect Dis. 2018,217(8):1267-79(通讯作者)

[16] Hu SF, He WT, Du XL, Yang JH, Wen Q, Zhong XP, Ma L*. IL-17 production of neutrophils enhances antibacteria ability but promotes arthritis development during Mycobacterium tuberculosis infection. Ebiomedicine. 2017,23:88-99(通讯作者)